Marketed varicella vaccine Clinical Trials
3 recruitingBiologic
Phase 33
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline900 enrolled12 locationsNCT06855160
Recruiting
Phase 3
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline600 enrolled3 locationsNCT06806137
Recruiting
Phase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline750 enrolled1 locationNCT06693895